BOK Financial Corporation Announces First Quarter 2025 Earnings Conference Call
The live audio webcast and presentation slides will be available on the company's investor relations website. The conference call can also be accessed by dialing 1.800.715.9871 toll free, or 1.646.307.1963, conference ID: 6617678. A webcast replay will be available shortly after the live call's conclusion on the company's investor relations website or by dialing 1.800.770.2030 and referencing replay PIN 6617678.
About BOK Financial Corporation
BOK Financial Corporation is a $50 billion regional financial services company headquartered in Tulsa, Oklahoma with $115 billion in assets under management and administration. The company's stock is publicly traded on NASDAQ under the Global Select market listings (BOKF). BOK Financial Corporation's holdings include BOKF, NA; BOK Financial Securities, Inc.; and BOK Financial Private Wealth, Inc. BOKF, NA's holdings include TransFund and Cavanal Hill Investment Management, Inc. BOKF, NA operates banking divisions across eight states as: Bank of Albuquerque; Bank of Oklahoma; Bank of Texas; and BOK Financial in Arizona, Arkansas, Colorado, Kansas and Missouri; as well as having limited purpose offices in Connecticut, Nebraska, Tennessee and Wisconsin. Through its subsidiaries, BOK Financial Corporation provides commercial and consumer banking, brokerage trading, investment, trust and insurance services, mortgage origination and servicing, and an electronic funds transfer network. For more information, visit www.bokf.com.
Contact:
Heather King
214.676.4666
SOURCE: BOK Financial Corp.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
33 minutes ago
- Yahoo
Prediction: Alphabet's Stock Will Deliver Monster Performance Over the Next 2 Years
Alphabet's stock trades at a deep discount to its peers. Alphabet's revenue and earnings growth are near the top compared to other "Magnificent Seven" stocks. 10 stocks we like better than Alphabet › Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) has been one of the most hated big tech stocks in the market over the past year. Despite posting consistently solid results, the market doesn't respect Alphabet's current business out of fear of what could happen to it. The primary question revolves around how Alphabet's legacy business (Google Search) will fare with the rise of generative AI. Investors are assuming that Google Search revenue will tumble, taking Alphabet's stock with it. However, that hasn't happened, and I doubt it will. I think Alphabet can deliver shareholders monster returns over the next two years through a combination of a few factors. Alphabet trades at a significant discount to other members of the "Magnificent Seven" cohort on a forward price-to-earnings (P/E) basis (Tesla has been removed from this chart because it trades for more than 160 times forward earnings). Now, some stocks deserve a premium valuation, such as Nvidia, because it is growing its revenue and earnings at a rapid pace. However, I'd argue that other companies, like Microsoft and Apple, don't deserve nearly the premium due to their growth rates. During the first quarter, Alphabet's growth rates, both in terms of revenue and earnings per share (EPS), were quite strong (I omitted Nvidia from this chart due to its rapid growth skewing the data). Alphabet's revenue growth was in the middle of the pack, but much closer to second place than it was fourth place. Additionally, its EPS growth was the second-best of the five companies. If I presented you with this information alone, you'd assume that the multiple Alphabet assigned should be in the middle to high end of this cohort's range. However, it trades at about a 50% discount to the second-cheapest member of the cohort, Meta Platforms. So, what could happen if Alphabet receives a respectable multiple? The remaining four companies in the analysis (Microsoft, Apple, Meta Platforms, and Amazon) trade for an average of 31.3 times forward earnings. Should market conditions remain the same and Alphabet climb to 31.3 times forward earnings to be at the average valuation, the stock would rise by 68%. Now, that 68% doesn't include any growth that Alphabet will experience over the next few years; that's just for reaching the same valuation level as its peers. This will be a tall task to accomplish, as the market appears to be convinced that Alphabet will face some challenges ahead. However, I think it's underestimating the staying power that Google has and how the average person will be perfectly content using Google's AI search overviews for their AI model. This should keep Google at the top of its game and allow it to continue growing its revenue at a steady double-digit pace for the foreseeable future. It may take a few years for the market to come to its senses regarding Alphabet stock, but it will be a significant outperformer if it does. As another fun fact, if Alphabet were assigned a 31.3 times forward earnings multiple at today's prices, it would be tied with Microsoft as the second-largest company in the world by market cap. Alphabet appears to be one of the top big tech companies to buy today. It's posting just as good as results (if not better) than its peers, yet trades at a huge discount. If Alphabet can continue posting strong results, the market will eventually come around to see that Alphabet is worthy of the same premium as its peers. By buying today, you can take advantage of a large discount and enjoy significant returns as Alphabet's valuation rises to match that of its peers. Before you buy stock in Alphabet, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Alphabet wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $699,558!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $976,677!* Now, it's worth noting Stock Advisor's total average return is 1,060% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 30, 2025 Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to Meta Platforms CEO Mark Zuckerberg, is a member of The Motley Fool's board of directors. John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Keithen Drury has positions in Alphabet, Amazon, Meta Platforms, Nvidia, and Tesla. The Motley Fool has positions in and recommends Alphabet, Amazon, Apple, Meta Platforms, Microsoft, Nvidia, and Tesla. The Motley Fool recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy. Prediction: Alphabet's Stock Will Deliver Monster Performance Over the Next 2 Years was originally published by The Motley Fool Sign in to access your portfolio
Yahoo
38 minutes ago
- Yahoo
Patterson-UTI Reports 103 US Drilling Rigs Operating in May 2025
Patterson-UTI Energy Inc. (NASDAQ:PTEN) is one of the best high short interest stocks with huge upside potential. Earlier in June, Patterson-UTI Energy reported its drilling activity for May this year. For the whole month, the company had an average of 103 drilling rigs operating in the US. Looking at a broader period, the average number of drilling rigs operating in the US for the 2 months ended May 31 this year was 106. Average drilling rigs operating reported in Patterson-UTI Energy's monthly announcements represent the average number of the Company's drilling rigs that were earning revenue under a drilling contract in the US. A drilling site in the wilds of nature, highlighting the company's commitment to exploration. The company clarifies that the 'average drilling rigs operating' reported in their monthly announcements represent rigs that were actively earning revenue under a drilling contract in the US. Patterson-UTI cautions that this metric alone does not fully impact the company's operating results, as numerous other factors can influence financial performance as well. Patterson-UTI Energy Inc. (NASDAQ:PTEN) intends to continue providing monthly updates on drilling rig activity shortly after the end of each month. The company provides contract drilling services, integrated well completion services, and directional drilling services in the US, as well as specialized drill bit solutions in the US, the Middle East, and other international regions. While we acknowledge the potential of PTEN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
38 minutes ago
- Yahoo
Leerink Partners Reiterates a Bullish Stance on Travere Therapeutics (TVTX)
Travere Therapeutics, Inc. (NASDAQ:TVTX) is one of the 13 Best Pharma Stocks to Buy According to Wall Street Analysts. On June 16, Leerink Partners analyst Joseph Schwartz reiterated the firm's bullish stance on Travere Therapeutics, Inc. (NASDAQ:TVTX), assigning it a Buy rating and a $42 price target. The analyst supported the positive rating with Travere Therapeutics, Inc.'s (NASDAQ:TVTX) positive trajectory, supported by its product Filspari, which attained complete approval for the treatment of IgA nephropathy (IgAN) in 2023. A laboratory technician working on a solution of rare diseases, housed in a cholic acid capsule. When considered in conjunction with the updated treatment guidelines, this approval has resulted in a notable growth in Filspari's market presence. Although competition is anticipated to rise in the IgAN market, the firm anticipates Filspari to hold a competitive market edge due to its full approval status, as other treatments only have accelerated approval. Schwartz also reasoned that Travere Therapeutics, Inc. (NASDAQ:TVTX) is looking into expansion opportunities in focal segmental glomerulosclerosis (FSGS), and a supplemental New Drug Application is under review by the FDA. While such processes have inherent regulatory risks, the analyst expressed optimism about Travere Therapeutics, Inc.'s (NASDAQ:TVTX) prospects because of its strategic positioning and management's confidence. Guggenheim analyst Vamil Divan also reiterated a Buy rating on Travere Therapeutics, Inc.'s (NASDAQ:TVTX) on July 2 with a price target of $47.00. Travere Therapeutics, Inc. (NASDAQ:TVTX) is a biopharmaceutical company that identifies, develops, and delivers therapies for rare kidney and metabolic diseases. Its product, FILSPARI (sparsentan), reduces proteinuria in individuals with primary IgAN at risk of rapid disease progression. The company's commercial products, Thiola and Thiola EC, treat cystinuria, a rare genetic cystine transport disorder. While we acknowledge the potential of TVTX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
